☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Pharma
ABL Bio Collaborates with Merck to Develop ABL103 Plus Keytruda for Treating Solid Tumors
October 4, 2024
Prime Medicine and BMS Join Forces to Develop and Commercialize Various Prime Edited Ex Vivo T-Cell Therapies
October 1, 2024
Orion and Aitia Join Forces for AI-Based Drug Discovery and Drug Simulation in Oncology
September 26, 2024
Generate:Biomedicines Partners with Novartis for the Discovery of Protein Therapeutics in Various Indications
September 24, 2024
BioAtla Join Forces with Context Therapeutics to Develop and Commercialize BA3362 for Cancer Treatment
September 24, 2024
PharmaJet Join Forces with Scancell to Develop and Commercialize Needle-free DNA Vaccine for Advanced Melanoma
September 18, 2024
Load more...
Back to Home
Modal title
×
Modal body text goes here.